These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33012458)

  • 41. Hepatocellular carcinoma in patients with chronic renal disease: Challenges of interventional treatment.
    Sarno G; Montalti R; Giglio MC; Rompianesi G; Tomassini F; Scarpellini E; De Simone G; De Palma GD; Troisi RI
    Surg Oncol; 2021 Mar; 36():42-50. PubMed ID: 33307490
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Hepatocellular carcinoma : updated management guidelines].
    Goossens N; Koessler T; Spahr L; Negro F
    Rev Med Suisse; 2018 Aug; 14(616):1508-1511. PubMed ID: 30156784
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatocellular adenoma: Where are we now?
    Wang X; Zhang X
    World J Gastroenterol; 2022 Apr; 28(14):1384-1393. PubMed ID: 35582672
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatocellular carcinoma: Epidemiology, pathogenesis and surveillance - implications for sub-Saharan Africa.
    Zakharia K; Luther CA; Alsabbak H; Roberts LR
    S Afr Med J; 2018 Aug; 108(8b):35-40. PubMed ID: 30182911
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Hepatocellular adenoma in 20 patients; recommendations for treatment].
    de Wilt JH; de Man RA; Laméris JS; Zondervan PE; Tilanus HW; IJzermans JN
    Ned Tijdschr Geneeskd; 1998 Nov; 142(45):2459-63. PubMed ID: 10028326
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Understanding the role of radiologists in complex treatment decisions for patients with hepatocellular carcinoma.
    Kamal O; Horvat N; Arora S; Chaudhry H; Elmohr M; Khanna L; Nepal PS; Wungjramirun M; Nandwana SB; Shenoy-Bhangle AS; Lee J; Kielar A; Marks R; Elsayes K; Fung A
    Abdom Radiol (NY); 2023 Dec; 48(12):3677-3687. PubMed ID: 37715846
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pivoting to telemedicine in a single-day multidisciplinary liver tumor clinic during COVID-19: the Texas Liver Tumor Center experience.
    Crow KS; Poordad FF; Halff GA; Cigarroa FG; Tsai E; Infante IV; Arora SP
    Ann Palliat Med; 2023 Nov; 12(6):1310-1317. PubMed ID: 37953220
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Advances in management of hepatocellular carcinoma.
    Allaire M; Nault JC
    Curr Opin Oncol; 2017 Jul; 29(4):288-295. PubMed ID: 28509806
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan.
    ; ; ; ; ; ; ; ; ;
    J Formos Med Assoc; 2018 May; 117(5):381-403. PubMed ID: 29074347
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Surgical resection and liver transplantation for hepatocellular carcinoma.
    Akoad ME; Pomfret EA
    Clin Liver Dis; 2015 May; 19(2):381-99. PubMed ID: 25921669
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Healthcare Costs Related to Treatment of Hepatocellular Carcinoma Among Veterans With Cirrhosis in the United States.
    Kaplan DE; Chapko MK; Mehta R; Dai F; Skanderson M; Aytaman A; Baytarian M; D'Addeo K; Fox R; Hunt K; Pocha C; Valderrama A; Taddei TH;
    Clin Gastroenterol Hepatol; 2018 Jan; 16(1):106-114.e5. PubMed ID: 28756056
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alternative HCC prognostic biomarkers and use of artificial intelligence in the management of HCC.
    Jaffe A; Taddei TH; Giannini EG; Ilagan-Ying YC; Colombo M; Strazzabosco M
    Liver Int; 2023 Jan; 43(1):258-259. PubMed ID: 36426717
    [No Abstract]   [Full Text] [Related]  

  • 53. An evidence-based multidisciplinary approach to the management of hepatocellular carcinoma (HCC): the Alberta HCC algorithm.
    Burak KW; Kneteman NM
    Can J Gastroenterol; 2010 Nov; 24(11):643-50. PubMed ID: 21157578
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Multidisciplinary Team Approach to the Management of Patients with Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
    Cheng S; Wei X; Shi J; Guo W; Feng S; Zhai J; Huang B
    Oncologist; 2020 Jun; 25(6):e998. PubMed ID: 32141691
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Advances in Management of Hepatocellular Carcinoma.
    Intaraprasong P; Siramolpiwat S; Vilaichone RK
    Asian Pac J Cancer Prev; 2016; 17(8):3697-703. PubMed ID: 27644603
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Current management of hepatocellular cancer.
    Rampone B; Schiavone B; Confuorto G
    Curr Oncol Rep; 2010 May; 12(3):186-92. PubMed ID: 20425078
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Systemic therapy for hepatocellular carcinoma (HCC): from bench to bedside.
    Abdel-Rahman O
    J Egypt Natl Canc Inst; 2013 Dec; 25(4):165-71. PubMed ID: 24207088
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A review of liver masses in pregnancy and a proposed algorithm for their diagnosis and management.
    Cobey FC; Salem RR
    Am J Surg; 2004 Feb; 187(2):181-91. PubMed ID: 14769302
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quality of Cancer Care in Patients with Cirrhosis and Hepatocellular Carcinoma.
    Dhanasekaran R; Talwalkar JA
    Curr Gastroenterol Rep; 2015 Sep; 17(9):34. PubMed ID: 26238927
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk factors of mortality in the patients with hepatocellular carcinoma: A multicenter study in Indonesia.
    Jasirwan COM; Hasan I; Sulaiman AS; Lesmana CRA; Kurniawan J; Kalista KF; Nababan SH; Gani RA
    Curr Probl Cancer; 2020 Feb; 44(1):100480. PubMed ID: 31130257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.